Amy L. Vāvere
YOU?
Author Swipe
View article: Automated radiosynthesis of [18F]fluoromannitol for clinical research on a commercially available trasis allinone radiosynthesizer
Automated radiosynthesis of [18F]fluoromannitol for clinical research on a commercially available trasis allinone radiosynthesizer Open
An automated method for the radiochemical synthesis of [18F]fluoromannitol was developed and optimized on a commercially available Trasis AllinOne radiosynthesizer. This method allows for the reliable production and global disse…
View article: Automated Radiosynthesis of [18F]Fluoromannitol for Clinical Research on a Commercially Available Trasis AllinOne Radiosynthesizer
Automated Radiosynthesis of [18F]Fluoromannitol for Clinical Research on a Commercially Available Trasis AllinOne Radiosynthesizer Open
Background : Infections pose a significant risk to immunocompromised individuals, and accurate, efficient diagnosis remain challenging. Current imaging methods like MRI and FDG PET lack pathogen specificity which complicate diagnosis and l…
View article: Automated radiosynthesis of [18F]DPA-714 on a commercially available IBA Synthera®
Automated radiosynthesis of [18F]DPA-714 on a commercially available IBA Synthera® Open
View article: [11C]-methionine positron emission tomography in the evaluation of pediatric low-grade gliomas
[11C]-methionine positron emission tomography in the evaluation of pediatric low-grade gliomas Open
Background [11C]-Methionine positron emission tomography (PET; [11C]-MET-PET) is principally used for the evaluation of brain tumors in adults. Although amino acid PET tracers are more commonly used in the evaluation of pediatric brain tum…
View article: Design and Manufacture of a Test Device for Radiosynthesizer Vacuum Pumps
Design and Manufacture of a Test Device for Radiosynthesizer Vacuum Pumps Open
Vacuum pump wear is the most prevalent failure mode of the IBA Synthera® automated radiochemistry system. Rebuilding or replacing the pump causes equipment downtime and increases the radiation exposure of the service personnel. We built a …
View article: Data from Positron Emission Tomography Detects <i>In Vivo</i> Expression of Disialoganglioside GD2 in Mouse Models of Primary and Metastatic Osteosarcoma
Data from Positron Emission Tomography Detects <i>In Vivo</i> Expression of Disialoganglioside GD2 in Mouse Models of Primary and Metastatic Osteosarcoma Open
The cell membrane glycolipid GD2 is expressed by multiple solid tumors, including 88% of osteosarcomas and 98% of neuroblastomas. However, osteosarcomas are highly heterogeneous, with many tumors exhibiting GD2 expression on <50% of the in…
View article: Data from Positron Emission Tomography Detects <i>In Vivo</i> Expression of Disialoganglioside GD2 in Mouse Models of Primary and Metastatic Osteosarcoma
Data from Positron Emission Tomography Detects <i>In Vivo</i> Expression of Disialoganglioside GD2 in Mouse Models of Primary and Metastatic Osteosarcoma Open
The cell membrane glycolipid GD2 is expressed by multiple solid tumors, including 88% of osteosarcomas and 98% of neuroblastomas. However, osteosarcomas are highly heterogeneous, with many tumors exhibiting GD2 expression on <50% of the in…
View article: Supplementary Data from Positron Emission Tomography Detects <i>In Vivo</i> Expression of Disialoganglioside GD2 in Mouse Models of Primary and Metastatic Osteosarcoma
Supplementary Data from Positron Emission Tomography Detects <i>In Vivo</i> Expression of Disialoganglioside GD2 in Mouse Models of Primary and Metastatic Osteosarcoma Open
Combined Supplementary Data file containing: Figure S1-Detailed ex vivo biodistribution data for three additional PDX tumors. Only summary data included in the manuscript Table 1. Figure S2-Multimodality imaging protocol. Figure S3-Ex vivo…
View article: Supplementary Data from Positron Emission Tomography Detects <i>In Vivo</i> Expression of Disialoganglioside GD2 in Mouse Models of Primary and Metastatic Osteosarcoma
Supplementary Data from Positron Emission Tomography Detects <i>In Vivo</i> Expression of Disialoganglioside GD2 in Mouse Models of Primary and Metastatic Osteosarcoma Open
Combined Supplementary Data file containing: Figure S1-Detailed ex vivo biodistribution data for three additional PDX tumors. Only summary data included in the manuscript Table 1. Figure S2-Multimodality imaging protocol. Figure S3-Ex vivo…
View article: Automated Radiosynthesis of [18f]Dpa-714 on a Commercially Available Iba Synthera®
Automated Radiosynthesis of [18f]Dpa-714 on a Commercially Available Iba Synthera® Open
View article: Design and Manufacture of a Test Device for Small Vacuum Pumps
Design and Manufacture of a Test Device for Small Vacuum Pumps Open
Vacuum pump wear is the most prevalent failure mode of the IBA Synthera® automated radiochemistry system. Rebuilding or replacing the pump causes equipment downtime and increases the radiation exposure of the service personnel. We buil…
View article: Positron Emission Tomography Detects <i>In Vivo</i> Expression of Disialoganglioside GD2 in Mouse Models of Primary and Metastatic Osteosarcoma
Positron Emission Tomography Detects <i>In Vivo</i> Expression of Disialoganglioside GD2 in Mouse Models of Primary and Metastatic Osteosarcoma Open
The cell membrane glycolipid GD2 is expressed by multiple solid tumors, including 88% of osteosarcomas and 98% of neuroblastomas. However, osteosarcomas are highly heterogeneous, with many tumors exhibiting GD2 expression on <50% of the…